Loading clinical trials...
Loading clinical trials...
To compare the efficacy of three strategies of lifestyle changes associated with Januvia (sitagliptin) 100 mg/day in patients with Type 2 Diabetes Mellitus (T2DM) inadequately controlled by metformin ...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Merck Sharp & Dohme LLC
NCT02088658 · Diabetes Mellitus, Type 2, Diabetes Mellitus, Adult-Onset, and more
NCT02113163 · Diabetes Mellitus, Non-Insulin-Dependent, Hypertriglyceridemia
NCT00004992 · Diabetes Mellitus, Non-Insulin-Dependent, Glucose Intolerance
NCT02541734 · Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus
NCT02662400 · Diabetes Mellitus, Non-Insulin-Dependent
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions